Search alternatives:
host resistance » plant resistance (Expand Search)
heat resistance » plant resistance (Expand Search), high resistance (Expand Search), rust resistance (Expand Search)
decrease tumor » increased tumor (Expand Search)
decrease heat » release heat (Expand Search)
release host » release heat (Expand Search), release soil (Expand Search)
Showing 21 - 40 results of 2,338 for search '(( release host resistance ) OR ((( decrease tumor resistance ) OR ( decrease heat resistance ))))', query time: 0.61s Refine Results
  1. 21
    Cabozantinib significantly decreases tumor volume and prolongs survival in SCNPC PDX models.

    Cabozantinib significantly decreases tumor volume and prolongs survival in SCNPC PDX models. by Mark P. Labrecque (10011469)

    Published 2021
    Save to List
    Saved in:
  2. 22
    A heat map to compare the associated resistances outlined in Table 1 and [14] with the IRP values.

    A heat map to compare the associated resistances outlined in Table 1 and [14] with the IRP values. by J. Roadnight Sheehan (20141887)

    Published 2024
    Save to List
    Saved in:
  3. 23
    Supplementary Data TS1 from Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance

    Supplementary Data TS1 from Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistanc... by Niklas Klümper (15048887)

    Published 2025
    Save to List
    Saved in:
  4. 24
    Supplementary Data from SENP1 Decreases RNF168 Phase Separation to Promote DNA Damage Repair and Drug Resistance in Colon Cancer

    Supplementary Data from SENP1 Decreases RNF168 Phase Separation to Promote DNA Damage Repair and Drug Resistance in Colon Cancer by Min Wei (16918572)

    Published 2025
    Save to List
    Saved in:
  5. 25
    Supplementary Data from SENP1 Decreases RNF168 Phase Separation to Promote DNA Damage Repair and Drug Resistance in Colon Cancer

    Supplementary Data from SENP1 Decreases RNF168 Phase Separation to Promote DNA Damage Repair and Drug Resistance in Colon Cancer by Min Wei (16918572)

    Published 2025
    Save to List
    Saved in:
  6. 26
    <i>PGRP-LC</i> knockdown in gut mitigates the decrease in lifespan caused by heat-killed <i>A</i>. <i>persici</i>.

    <i>PGRP-LC</i> knockdown in gut mitigates the decrease in lifespan caused by heat-killed <i>A</i>. <i>persici</i>. by Taro Onuma (15195377)

    Published 2023
    Save to List
    Saved in:
  7. 27
    SOCS-1 impairs skin host defense in hyperglycemic mice.

    SOCS-1 impairs skin host defense in hyperglycemic mice. by Nathan Klopfenstein (3044217)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  8. 28
    Western blot analysis of BbAFP1 released into CZA medium.

    Western blot analysis of BbAFP1 released into CZA medium. by Sheng Tong (1399951)

    Published 2020
    Save to List
    Saved in:
  9. 29
    Drug combinations with trametinib decrease the colony-forming ability of GIST cell lines.

    Drug combinations with trametinib decrease the colony-forming ability of GIST cell lines. by Anu Gupta (467592)

    Published 2021
    Save to List
    Saved in:
  10. 30
    Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    “…Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…”
    Save to List
    Saved in:
  11. 31
    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    “…Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…”
    Save to List
    Saved in:
  12. 32
    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    “…Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…”
    Save to List
    Saved in:
  13. 33
    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    “…Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…”
    Save to List
    Saved in:
  14. 34
    Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    “…Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…”
    Save to List
    Saved in:
  15. 35
    Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    “…Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…”
    Save to List
    Saved in:
  16. 36
    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    “…Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…”
    Save to List
    Saved in:
  17. 37
    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    “…Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…”
    Save to List
    Saved in:
  18. 38
    Novel chromobox 2 inhibitory peptide decreases tumor progression

    Novel chromobox 2 inhibitory peptide decreases tumor progression by Lindsay W. Brubaker (15099942)

    Published 2023
    Save to List
    Saved in:
  19. 39
    Supplementary Figure 3 from Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression

    Supplementary Figure 3 from Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression by Thomas J. Rogers (8041841)

    Published 2023
    Save to List
    Saved in:
  20. 40
    Supplementary Figure 2 from Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression

    Supplementary Figure 2 from Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression by Thomas J. Rogers (8041841)

    Published 2023
    Save to List
    Saved in:

Search Tools: